Gastric cancer: Laboratory bench to clinic

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 4, 2002, Pages 495-502

  Houghton, Jeanmarie ^a   Fox, James G ^b   Wang, Timothy C ^c  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Department of Medicine University of Massachusetts Medical Center NRB ^*

Author keywords

Dietary factors; Epidemiology; Gastric atrophy; Gastric cancer; Gastrin; Helicobacter pylori; Pathogenesis; Th1 immune response

Indexed keywords

ALPHA CATENIN; APC PROTEIN; BETA CATENIN; CYCLOOXYGENASE 2; FAS ANTIGEN; FAS LIGAND; FLUOROURACIL; FOLINIC ACID; FRAGILE HISTIDINE TRIAD PROTEIN; GAMMA INTERFERON; GASTRIN 17; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MYC PROTEIN; PROGASTRIN; PROTEIN P53; RAS PROTEIN; SCATTER FACTOR; TREFOIL PEPTIDE; TREFOIL PEPTIDE 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN;

APOPTOSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CONFERENCE PAPER; DIET; DISEASE COURSE; ENVIRONMENTAL FACTOR; GENE DELETION; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK PATIENT; HOST; HUMAN; IMMUNE RESPONSE; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH ACID SECRETION; STOMACH ADENOCARCINOMA; STOMACH MUCOSA; TH1 CELL;

EID: 0036094306     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02770.x     Document Type: Conference Paper

References (52)

1. Estimates of the worldwide frequency of sixteen major cancers in 1980
2. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer
3. Gastric cancer: Past, present and future
4. E-Cadherin germline mutations in familial gastric cancer
5. Occurrence of p53 gene abnormalities I gastric carcinoma tumors and cell lines
6. No evidence for point mutations in codons 12, 13 and 61 of the ras gene in a high-incidence area for esophageal and gastric cancers
7. The molecular biology of esophageal and gastric cancer and their precursors: Oncogenes, tumor suppressor genes and growth factors
8. Genetic, dietary and environmental factors in the pathogenesis of gastric cancer: Study of a high incidence family
9. The Fas pathway is associated with intestinal but not diffuse type gastric adenocarcinoma
10. Schistosomes, liver flukes and Helicobacter pylori. Lyon, June 7-14, 1994
11. Long-term sequelae of Helicobacter pylori gastritis
12. A human model of gastric carcinogenesis
13. Helicobacter pylori and gastric cancer
14. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection
15. Helicobacter pylori infection and the development of gastric cancer
16. Helicobacter pylori factors associated with disease development
17. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori
18. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells
19. The decline in gastric cancer: Epidemiology of an unplanned triumph
20. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice
21. The risk of stomach cancer in patients with gastric or duodenal ulcer disease
22. Acid, ulcers and H. pylori
23. The gastrins: Their biological activities
24. Circulating hormones in peptic ulcer disease
25. Carboxyl terminal glycine extended progastrin (gastrin-G) in gastric antral mucoasa of patients with gastric or duodenal ulcer and in gastrinomas
26. Glycine extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice
27. Circulating cytokines and gastrin levels in asymptomatic subjects infected by Helicobacter pylori
28. Helicobacter pylori infection and exaggerated gastrin release: Effects of inflammation and progastrin processing
29. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer
30. The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice
31. Cellular immune responses are essential for the development of Helicobacter felis-associated gastric pathology
32. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection
33. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4 but not IFN-gamma, gene-deficient mice
34. Dominant non-responsiveness to Helicobacter pylori infection is associated with production of interleukin 10 but not gamma interferon
35. Helicobactor pylori: The African enigma
36. Concurrent enteric helminth infection modulates inflammation, gastric immune responses and reduces Helicobacter induced gastric atrophy
37. Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori
38. Characteristics of the gastric mucosa of direct relatives of patients with sporadic gastric carcinoma
39. Interleukin 1 polymorphisms associated with increased risk of gastric cancer
40. Microsatellite instability and loss of heterozygosity in gastric carcinoma in comparison to family history
41. Proinflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas
42. Tumor necrosis factor alpha and interleukin 1β up-regulate gastric mucosal Fas antigen expression in Helicobacter pylori infection
43. In vivo disruption of the Fas pathway abrogates gastric growth alterations secondary to Helicobacter infection
44. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
45. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury
46. 2 show altered apoptosis differentiation with Helicobacter felis infection
47. MNNG-induced gastric carcinoma in ferrets infected with Helicobacter mustelae
48. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils
49. Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer
50. Modeling cost effectiveness of H. pylori screening to prevent gastric cancer: A mandate for clinical trials
51. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated
52. Helicobacter pylori infection and the development of gastric cancer